Part D Price Negotiation Provision In House Reform Bill Missing Its Teeth?
Executive Summary
The House health care reform bill passed by the Energy and Commerce Committee directs HHS to negotiate drug prices directly with manufacturers for the Medicare Part D program, but it does not authorize HHS to establish a national formulary
You may also be interested in...
HHS Envisions Drug Price Arbitration For Part D
Approaches for HHS to become involved in drug price negotiations between Medicare Part D plan sponsors and manufacturers were outlined by HHS Assistant Secretary for Planning and Evaluation Richard Frank at a policy conference, although current law would need to be revised to allow it.
Merged House Bill Seeks More Part D Savings, Broader Medicaid Expansion
The health care reform bill unveiled by the House leadership Oct. 29 seeks increased drug savings for the Medicare Part D program through mandated rebates for products provided to low-income beneficiaries and by requiring HHS to negotiate drug pricing directly with manufacturers
Merged House Bill Seeks More Part D Savings, Broader Medicaid Expansion
The health care reform bill unveiled by the House leadership Oct. 29 seeks increased drug savings for the Medicare Part D program through mandated rebates for products provided to low-income beneficiaries and by requiring HHS to negotiate drug pricing directly with manufacturers